On the basis of the work presented and discussed at the
• Serologic assays for diagnosis of C. jejuni infections need to be standardized and validated. workshop, a number of key points can be summarized, and from these, a series of recommendations can be made. These
• All patients with acute flaccid paralysis should have their stools cultured for Campylobacter, and all isolated strains points are divided into the following categories: diagnostic aspects, epidemiology and surveillance, microbiology and should be serotyped.
• Antibiotic resistance among Campylobacter species needs pathogenesis studies, and information management.
to be monitored worldwide.
Diagnostic Aspects
Epidemiology and Surveillance Although there is substantial immunologic evidence linking the development of Guillain-Barré syndrome (GBS) with a
The medical costs associated with Campylobacter-induced preceding infection with Campylobacter jejuni, microbiologic GBS have been estimated by the US Department of Agriculture evidence is less complete. This is likely due to the brief period to be $57 -$420 million per year in the United States. Total of excretion of C. jejuni in stools (median, 16 days) after an costs, which include days of lost productivity, are estimated to acute infection. Symptoms of GBS typically occur 10 days to be between $247 million and $1.8 billion per year. Clearly, 3 weeks after C. jejuni infection, when many patients have
Campylobacter-induced GBS is a disease with a significant already cleared their stools. As such, studies of C. jejuni seroeconomic impact in this country. types associated with GBS are limited to a small number of Although GBS can probably result following a number of strains. If diarrheal cases were more frequently screened for bacterial and viral infections, infection with C. jejuni is the C. jejuni, and if more and better typing reagents were available, most often recognized preceding event. However, the epidemithe epidemiologic link between preceding infection with particology of infection with the campylobacters associated with ular strains and the development of GBS would become better GBS is not well understood. In particular, the specific reservoirs established. In addition, antibiotic resistance is emerging for GBS-related strains have not been identified. Although there among Campylobacter species in both developing and develis a marked seasonal pattern of C. jejuni infection (summer) oped countries. This could lead to difficulties in the treatment of in some countries, there is no clear seasonal variation in the human disease, and resistance enhances the need for protective incidence of GBS. An exception has been observed in northern vaccination of animals raised for food or of humans (or both).
China, where outbreaks of GBS occur among children every The following recommendations can be made: summer and fall.
• Diagnostic tests sensitive for detection of a variety of
With the inclusion of C. 
